Icell Kealex Therapeutics Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Icell Kealex Therapeutics General Information

Description

Developer of T-cell virus. The specializes in developing a T-cell engager-armed virus for the treatment of solid tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • Houston, TX
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Icell Kealex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Mar-2016 Completed Startup
To view Icell Kealex Therapeutics’s complete valuation and funding history, request access »

Icell Kealex Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
To view Icell Kealex Therapeutics’s complete investors history, request access »